Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study tracks childhood cancer survivors to uncover late effects

NCT ID NCT01518400

First seen Jun 21, 2026 · Last updated Jun 21, 2026

Summary

This study creates a research database of 5,000 childhood cancer survivors treated at Children's Hospital Los Angeles. By collecting health information from follow-up visits, researchers aim to identify risk factors for late effects—complications that can appear years after treatment—and develop ways to improve survivors' health and quality of life. Participants must have been diagnosed with cancer at age 21 or younger and be off treatment and disease-free.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's Hospital Los Angeles

    RECRUITING

    Los Angeles, California, 90027, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this database could help identify risk factors and develop interventions to improve health and quality of life for childhood cancer survivors.

What could go wrong

This is an observational database study, not a treatment trial. It may not directly lead to new therapies, and results depend on the quality and completeness of the data collected.

Conditions

The condition(s) this trial relates to.

Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.